Business Wire

Helfie AI Bolsters Operational and Strategic Growth With Appointment of Two Influential Industry Leaders to Executive Team

31.7.2025 14:00:00 CEST | Business Wire | Press release

Share

Leadership roles will support continued growth of Helfie AI’s Human Health Network across B2B audiencesKey near-term initiatives will include the official consumer launch of the company’s mobile health checks worldwide

Helfie AI, aglobal mobile health platform, today announced the appointment of two new members of the executive leadership team, Stefan Kulik as Chief Operating Officer and Rania Awad as Chief Strategy Officer.

Helfie AI is building the world’s first human health platform, powered by artificial intelligence, to enable anyone with a smartphone anywhere in the world access to easy, instant and affordable health checks. The additions of Mr. Kulik and Ms. Awad to the leadership team strengthens Helfie AI’s capacity to deliver an AI solution to healthcare that emphasizes data ownership, universal access and freedom of choice, enabling early disease detection and prevention on a global scale.

Helfie AI co-founder and CEO George Tomeski said: “The expansion of our leadership team to include Stefan and Rania is a pivotal moment in Helfie’s growth. As we reach across communities worldwide and deliver on our vision of providing an accurate and cost-effective way for patients to obtain health checks, we will rely on their expertise to realize this mission. I look forward to working with them as we continue to develop our Human Health Network platform to bring it to all 8 billion humans worldwide.”

Kulik has over 15 years of experience serving in executive roles at recognizable companies such as PepsiCo, Johnson & Johnson, and Royal Mail. In each of these leadership roles he developed deep expertise in operational excellence and business development. Kulik also has significant experience in private equity and venture capital environments, with specialized knowledge in predictive analytics and artificial intelligence applications. His unique combination of corporate leadership experience and insights gained from working with elite athletes in performance optimization and behavioural change positions him well to drive Helfie AI's continued growth and strategic objectives.

Awad is an accomplished digital strategist and innovator with extensive experience as a licensed pharmacist and business leader. She brings a proven track record of scaling organizations, spearheading digital transformation initiatives, and developing comprehensive product and go-to-market strategies. Her cross-industry expertise spans healthcare, asset management, retail and information technology sectors, with demonstrated success across the Asia-Pacific region, including Australia, New Zealand, and China. Awad's unique combination of pharmaceutical expertise and strategic business acumen positions her to drive Helfie's strategic vision and market expansion objectives.

​“Helfie AI is revolutionising the healthcare field by providing consumers with a cost-effective and accurate AI-powered platform, so I look forward to applying my organisational expertise to help achieve this vision on a global scale,” said Kulik. “As we expand Helfie AI’s global growth strategy within the UK, broader international markets, and the US, I will work with my colleagues to bring this critical technology to those who need it most.”

“Helfie AI’s technology aims to bring equitable health access globally to bypass complicated healthcare systems and put AI-powered mobile health checks into individual hands,” said Awad. "In the near-term, I will use my expertise in strategic marketing to help Helfie AI achieve its next stage of growth, which includes a consumer launch and expanded partnerships with organizations and governments worldwide. I’m confident that the expanded leadership team will deliver on Helfie AI’s mission to become the most trusted AI health company in the market.”

Helfie AI's advanced AI technologies analyse pictures, videos, sound recordings or face scans to check for indications of potential health conditions. Helfie AI generates instant results and offers the user information and options on what to do next. Importantly, the user owns and controls all of the data provided as part of the checks.

About Helfie AI
Helfie AI was founded in Melbourne, Australia in 2021 and has expanded operations to Europe, North America, Africa and Asia with multiple active B2B partnerships with top tier companies already in place.

Helfie AI tackles two of healthcare’s most fundamental challenges: the lack of participation in preventative healthcare and the under-utilisation of health data. Every facet of healthcare, starting with the quality and longevity of human life, can be dramatically improved if everyone actively participates in preventative health and if health data is actively utilized throughout the healthcare system.

The accessibility made possible by Helfie AI can significantly reduce the $7 trillion spent annually on treating preventable conditions.

Helfie AI provides users with clear next steps, connects them to medical care if/as required, allows interaction around numerous health conditions, from cardiovascular to skin health, and enables sharing AI findings with their own carers and doctors.

More details on the checks Helfie can make are available at www.helfie.ai

View source version on businesswire.com: https://www.businesswire.com/news/home/20250731802386/en/

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Visa Opens the Door to AI-Driven Shopping for Businesses Worldwide8.4.2026 18:00:00 CEST | Press release

Part of the Visa Intelligent Commerce portfolio, Intelligent Commerce Connect will enable more ways for agents to pay and merchants to accept agentic transactions in a single integrationCurrently in pilot with select partners including Aldar, AWS, Diddo, Highnote, Mesh, Payabli, Sumvin, and rolling out to more partners this year Visa Inc. (NYSE: V) today unveiled Intelligent Commerce Connect, a new solution that makes it easier for businesses to connect to and participate in AI-powered commerce. Intelligent Commerce Connect acts as a network, protocol, and token vault-agnostic ‘on ramp’ to agentic commerce for agent builders, merchants, and enablers. As consumers increasingly rely on AI agents to make purchases, businesses – whether they are building agents, selling to them, or processing transactions – need a simple way to get started. Intelligent Commerce Connect, part of the Visa Intelligent Commerce portfolio, meets that need. Through a single integration via the Visa Acceptance Pl

Sumitomo Corporation, SMBC Aviation Capital, Apollo and Brookfield Complete the Acquisition of Air Lease Corporation8.4.2026 15:13:00 CEST | Press release

Sumitomo Corporation, SMBC Aviation Capital, Apollo-managed funds (“Apollo”) and Brookfield today announced that they have completed the previously announced acquisition of Air Lease Corporation (“Air Lease”) and have renamed the business Sumisho Air Lease Corporation (“Sumisho Air Lease”). This transformational transaction improves the financial position of the business with long term support and aviation expertise from co-investors Sumitomo Corporation, SMBC Aviation Capital, Apollo and Brookfield. Sumisho Air Lease’s strong foundation as an established aircraft lessor, supported by SMBC Aviation Capital’s industry‑leading capabilities as servicer, creates a platform with the scale and financial strength needed to meet the fast‑changing and increasingly complex requirements of airline customers. Sumisho Air Lease will also benefit from the deep expertise and long-standing commitment that both Sumitomo Corporation and SMBC Aviation Capital bring to the global aviation leasing sector.

Sitetracker Launches Scout, an Agentic AI Platform Purpose-Built for Critical Infrastructure8.4.2026 15:00:00 CEST | Press release

Sitetracker, the leading Asset Lifecycle Management platform for critical infrastructure, today announced the launch of Scout, its new Agentic AI platform designed to help infrastructure owners, operators, and contractors gain deep insights and drive automation within their operations. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260408923336/en/ Scout, ready for real work As your AI analyst and agent, Scout is ready to work on day 1. Scout provides clarity when decisions are forming and momentum when action is required. It surfaces risk, synthesizes information, and helps accelerate execution by connecting data and driving action. Scout creates operational intelligence and turns it into action all in a secure environment that protects data sovereignty. “Our customers are looking to create compounding competitive advantages,” said Giuseppe Incitti, Chief Executive Officer of Sitetracker. “Scout delivers by providing easy t

Westinghouse Hosts Annual VVER Fuel Forum with Customers8.4.2026 15:00:00 CEST | Press release

Westinghouse currently has fuel supply contracts with all the European VVER operators Westinghouse and MVM Paks Nuclear Power Plant (NPP) recently co-hosted the VVER Fuel Forum in Budapest to share insights and plans for the continued deployment of VVER-1000 and VVER-440 fuel in operating reactors. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260408646373/en/ Participants to the VVER Fuel Forum Péter János Horváth, CEO of MVM Paks, welcomed all the participants, highlighting that Hungary is ending two decades of single supplier fuel dependency thanks to the agreement recently signed with Westinghouse to supply the VVER-440 NOVA E-6 fuel design. Six customers presented the progress made and positive outcomes achieved in the past years with the introduction of Westinghouse fuel into mixed cores with resident fuel in their reactors: Energoatom has extensive experience with Westinghouse VVER-440 and VVER-1000 fuel, currently u

Virica Biotech and FUJIFILM Biosciences Collaborate Under the Canada–Japan Co‑Innovation Program to Advance AAV Production Enhancers8.4.2026 15:00:00 CEST | Press release

Efficient production of Adeno-Associated Virus (AAV) vectors at scale for in vivo gene therapies remains a key bottleneck for broad patient access and sustainable manufacturing costs.Virica and FUJIFILM Biosciences will co-develop an off-the-shelf enhancer–media solution to boost AAV yields and process robustness in FUJIFILM Biosciences BalanCD® HEK293 system. Virica Biotech (“Virica”), a cell enhancer company specializing in Viral Sensitizers (VSE™) for viral vector manufacturing, today announced it is receiving advisory services and funding from the National Research Council of Canada Industrial Research Assistance Program (NRC IRAP), under the Canada–Japan Corporate Co-Innovation Program for a collaboration with FUJIFILM Biosciences. The collaboration will focus on optimizing a VSE™ formulation for FUJIFILM Biosciences BalanCD HEK293 media to support academic and commercial AAV producers globally. AAV vectors are a cornerstone of in vivo gene delivery for gene therapies, but they re

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye